期刊文献+

应用WS/T 514-2017新标准建立并验证输血前ELISA定性筛查八项的检出限 被引量:1

Establishing and Verifing Detection Limit for the Eight Items before Blood Transfusion with Enzyme-Linked Immunosorbent Assay by the WS/T 514-2017 Industry Standard Documents
下载PDF
导出
摘要 目的根据医院等级评定及ISO15189:2012的要求,对输血前酶联免疫法定性筛查八项的检出限进行评价。方法根据2017年新出台的卫生行业标准WS/T 514-2017∶《临床检验方法检出能力的确立和验证》中的概率单位方案建立输血前八项项目的检出限(limit of detection,LoD):在同一套检测系统中,使用2个试剂批号,每个批号连续4天,每天对5个评估浓度值标本重复检测5次,计算对应的命中率,将命中率转化为概率单位,与对应浓度值制作回归模型,将命中率为95%对应的概率单位1.645代入方程式中,所得的浓度值即为LoD估计值;对上述检出限估计值进行验证,连续3天检测对2个LoD声明浓度附近的标本(由标准物质稀释所得)重复检测4次,计算≥LoD声明的阳性结果百分比,≥临界值87%,则验证成功。结果各个项目的 LoD估计值为:乙型肝炎表面抗原0.100IU/ml,乙型肝炎表面抗体9.642 mIU/ml,乙型肝炎e抗原0.666NCU/ml,乙型肝炎e抗体3.700NCU/ml,乙型肝炎核心抗体0.786IU/ml,丙型肝炎病毒抗体0.506NCU/ml,梅毒螺旋体特异性抗体2.236mIU/ml,人类免疫缺陷病毒0.135NCU/ml。检出限估计值验证通过。结论验证项目在该实验室的检测方法及检测系统中的检出限满足要求。 Objective To evaluate the limit of detection of eight enzyme-linked immunosorbent assay(ELISA)according to hospital grade assessment and ISO15189:2012.Methods According to the new health industry standard WS/T 514-2017:"Establishment and verification of detection capability for clinical laboratory measurement procedures",the limit of detection(LoD)was established,in the sameset of detection system,using two reagent lot,each lot for 5 consecutive days 4 consecutive days to assess the value of the concentration of five specimens were detected repeatedly,calculated the corresponding hit rate,then transform into probability units,and the corresponding concentration value production regression model,the hit rate of 95% corresponds to the probability unit 1.645 substituted into the equation,the resulting concentration value was LoD estimates.The detection limit values were tested for 3 consecutive days of detection of two LoD concentrations near the declared concentration of the sample(diluted by the standard material)was detected 4 times repeatedly to calculate the positive result was greater than or equal to the percentage of LoD statement,greater than or equal to the critical value of 87%,then verified success.Results HBsAg:0.100 IU/ml,HBsAb:9.642 mIU/ml,HBeAg:0.666 NCU/ml,HBeAb:3.700 NCU/ml,HBcAb:0.786 IU/ml,HCV:0.506 NCU/ml,TP:2.236 mIU/ml and HIV:0.135 NCU/ml.The detection limit estimates were passed.Conclusion The verification limit of the verification project in the testing method and detection system of the laboratory meet the requirements Objective.
作者 岑伟明 梁宝环 黄明兰 黄媛萍 梁越媚 方凤媚 隋洪 CEN Wei-ming;LIANG Bao-huan;HUANG Ming-lan;HUANG Yuan-ping;LIANG Yue-mei;FANG Feng-mei;SUI Hong(Dongguan Kanghua Hospital ,Guangdong Dongguan 523080,Chin)
机构地区 东莞康华医院
出处 《现代检验医学杂志》 CAS 2018年第1期141-144,共4页 Journal of Modern Laboratory Medicine
关键词 酶联免疫吸附试验 概率单位方案 检出限 enzyme-linked immunosorbent assay probability unit scheme limit of detection
  • 相关文献

参考文献5

二级参考文献38

  • 1张玲霞,曲建慧.慢性乙型病毒性肝炎的治疗策略[J].中华医学杂志,2005,85(17):1153-1155. 被引量:20
  • 2曾健强,聂冬梅,马兰,叶贤林.深圳无偿献血乙肝筛查阳性结果确证分析[J].实用预防医学,2006,13(2):258-259. 被引量:4
  • 3孙蕾,郑松柏,徐建华,张秀明,林莲英.化学发光免疫法检测AFP的分析灵敏度核实实验及评价[J].现代检验医学杂志,2007,22(3):61-62. 被引量:8
  • 4杨有业,张秀明.临床检验方法学评价[M].北京:人民卫生出版社,2008:118-127.
  • 5刘成玉,罗春丽.临床检验基础[M].5版.北京:人民卫生出版社.2012:92.
  • 6CLSI. Protocols for Determination of Limits of Detection and Limits of Quantitation; Approved Guideline. CLSI document EP17-A. Wayne, PA: Clinical and Laboratory Standards Institute,2004.
  • 7CLSI. Evaluation of Detection Capability for Clinical Laboratory Meas- urement Procedures;Approved Guideline-Second Edition. CLSI docu- ment EP17-A2. Wayne, PA : Clinical and Laboratory Standards Institu- te,2012.
  • 8Ekins RP. The "precision profile" : its use in RIA assessment and de- sign. Ligand Quarterly, 1981,4(2) :33-44.
  • 9CLSI. Evaluation of Precision Performance of Quantitative Measurement Methods; Approved Guideline-Second Edition . CLSI document EP05-A2. Wayne, PA: Clinical and Laboratory Standards Institute, 2004.
  • 10Bliss CI. The method of probits. Science, 1934,79 (2037) :38-39.

共引文献45

同被引文献6

引证文献1

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部